Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Nov;76(3 Suppl 3):68–72. doi: 10.1136/hrt.76.3_suppl_3.68

The renin-angiotensin system and cardiac remodelling after acute myocardial infarction

H Ikram 1
PMCID: PMC484491  PMID: 8983667

Full text

PDF
68

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ambrosioni E., Borghi C., Magnani B. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med. 1995 Jan 12;332(2):80–85. doi: 10.1056/NEJM199501123320203. [DOI] [PubMed] [Google Scholar]
  2. Ball S. G., Hall A. S. What to expect from ACE inhibitors after myocardial infarction. Br Heart J. 1994 Sep;72(3 Suppl):S70–S74. doi: 10.1136/hrt.72.3_suppl.s70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chobanian A. V., Haudenschild C. C., Nickerson C., Drago R. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension. 1990 Mar;15(3):327–331. doi: 10.1161/01.hyp.15.3.327. [DOI] [PubMed] [Google Scholar]
  4. Cleland J. G., Poole-Wilson P. A. ACE inhibitors for heart failure: a question of dose. Br Heart J. 1994 Sep;72(3 Suppl):S106–S110. doi: 10.1136/hrt.72.3_suppl.s106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fletcher P. J., Pfeffer J. M., Pfeffer M. A., Braunwald E. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function. Circ Res. 1981 Sep;49(3):618–626. doi: 10.1161/01.res.49.3.618. [DOI] [PubMed] [Google Scholar]
  6. Foy S. G., Crozier I. G., Turner J. G., Richards A. M., Frampton C. M., Nicholls M. G., Ikram H. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study). Am J Cardiol. 1994 Jun 15;73(16):1180–1186. doi: 10.1016/0002-9149(94)90178-3. [DOI] [PubMed] [Google Scholar]
  7. Hutchins G. M., Bulkley B. H. Infarct expansion versus extension: two different complications of acute myocardial infarction. Am J Cardiol. 1978 Jun;41(7):1127–1132. doi: 10.1016/0002-9149(78)90869-x. [DOI] [PubMed] [Google Scholar]
  8. Katz A. M. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 1990 Jan 11;322(2):100–110. doi: 10.1056/NEJM199001113220206. [DOI] [PubMed] [Google Scholar]
  9. Køber L., Torp-Pedersen C., Carlsen J. E., Bagger H., Eliasen P., Lyngborg K., Videbaek J., Cole D. S., Auclert L., Pauly N. C. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N Engl J Med. 1995 Dec 21;333(25):1670–1676. doi: 10.1056/NEJM199512213332503. [DOI] [PubMed] [Google Scholar]
  10. Leung W. H., Lau C. P. Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction. J Am Coll Cardiol. 1992 Aug;20(2):307–313. doi: 10.1016/0735-1097(92)90095-5. [DOI] [PubMed] [Google Scholar]
  11. Pfeffer J. M., Pfeffer M. A., Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985 Jul;57(1):84–95. doi: 10.1161/01.res.57.1.84. [DOI] [PubMed] [Google Scholar]
  12. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  13. Pfeffer M. A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990 Apr;81(4):1161–1172. doi: 10.1161/01.cir.81.4.1161. [DOI] [PubMed] [Google Scholar]
  14. Pfeffer M. A., Pfeffer J. M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985 Aug;72(2):406–412. doi: 10.1161/01.cir.72.2.406. [DOI] [PubMed] [Google Scholar]
  15. Ray S. G., Pye M., Oldroyd K. G., Christie J., Connelly D. T., Northridge D. B., Ford I., Morton J. J., Dargie H. J., Cobbe S. M. Early treatment with captopril after acute myocardial infarction. Br Heart J. 1993 Mar;69(3):215–222. doi: 10.1136/hrt.69.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Rutherford J. D., Pfeffer M. A., Moyé L. A., Davis B. R., Flaker G. C., Kowey P. R., Lamas G. A., Miller H. S., Packer M., Rouleau J. L. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. Circulation. 1994 Oct;90(4):1731–1738. doi: 10.1161/01.cir.90.4.1731. [DOI] [PubMed] [Google Scholar]
  17. Schoemaker R. G., Debets J. J., Struyker-Boudier H. A., Smits J. F. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol. 1991 Feb;23(2):187–197. doi: 10.1016/0022-2828(91)90105-u. [DOI] [PubMed] [Google Scholar]
  18. Sharpe N., Murphy J., Smith H., Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet. 1988 Feb 6;1(8580):255–259. doi: 10.1016/s0140-6736(88)90347-9. [DOI] [PubMed] [Google Scholar]
  19. Sharpe N., Smith H., Murphy J., Greaves S., Hart H., Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet. 1991 Apr 13;337(8746):872–876. doi: 10.1016/0140-6736(91)90202-z. [DOI] [PubMed] [Google Scholar]
  20. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  21. Tan L. B., Hall A. S. Cardiac remodelling. Br Heart J. 1994 Oct;72(4):315–316. doi: 10.1136/hrt.72.4.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yusuf S., Pepine C. J., Garces C., Pouleur H., Salem D., Kostis J., Benedict C., Rousseau M., Bourassa M., Pitt B. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet. 1992 Nov 14;340(8829):1173–1178. doi: 10.1016/0140-6736(92)92889-n. [DOI] [PubMed] [Google Scholar]
  23. van Gilst W. H., de Graeff P. A., Scholtens E., de Langen C. D., Wesseling H. Potentiation of isosorbide dinitrate-induced coronary dilatation by captopril. J Cardiovasc Pharmacol. 1987 Feb;9(2):254–255. doi: 10.1097/00005344-198702000-00021. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES